- cafead   Dec 15, 2020 at 08:53: PM
via As Novartis launches its self-administered multiple sclerosis drug Kesimpta, rival Roche has been looking for a convenience boost with its earlier-to-market blockbuster Ocrevus—and it just snagged a U.S. go-ahead toward that goal.
article source
article source